Studying antiepileptic drugs in elderly patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the population pharmacokinetics, effectiveness, and safety of various antiepileptic drugs, including phenytoin, carbamazepine, lamotrigine, levetiracetam, and parempanel, specifically in elderly patients aged 65 and older. The study will analyze how these medications perform in this age group to recommend optimized dosage regimens. By focusing on elderly patients diagnosed with epilepsy who are currently using these medications, the research seeks to enhance treatment outcomes and minimize adverse effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥65 years old;
2. Diagnosed with epilepsy;
3. Using antiepileptic drugs for treatment;

Exclusion Criteria:

1. Patients who are expected to die within 48 hours;
2. Patients with allergy to antiepileptic drugs;
3. Patients receiving other investigational drugs;
4. Other factors that the researcher considers unsuitable for inclusion.

Where it's running

• Wei Zhao
  Jinan, Shandong, China Recruiting

Study contacts

• Study coordinator: Wei Zhao
• Email: zhao4wei2@hotmail.com
• Phone: 86053188383308

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Impact of new epilepsy diagnostic criteria on outcomes after a first seizure

  This study looks at how new guidelines for diagnosing epilepsy affect people who have just had their first seizure, focusing on their seizure frequency, medication use, quality of life, and thinking skills.

  Recruiting University Hospital Marburg · Marburg, Hesse · NCT06836687

• High-dose dexamethasone plus orelabrutinib versus placebo for newly diagnosed adult ITP

  This trial tests whether adding orelabrutinib to high-dose dexamethasone helps adults newly diagnosed with primary ITP raise and maintain their platelet counts compared with placebo.

  Recruiting Phase 3 Shandong University · Jinan, Shandong · NCT07559331

• Active magnetically controlled capsule endoscopy for small bowel navigation

  We will test whether a handheld magnetic controller can steer a capsule endoscope through the small bowel in patients already scheduled for enteroscopy.

  Recruiting Shandong University · Jinan, Shandong · NCT07325344

• Nurse-led transitional care for stroke survivors in Tanzania

  This study tests whether a nurse-led transitional care program helps Tanzanian stroke survivors and their caregivers feel more prepared for discharge, manage the condition better, and have a higher quality of life.

  Recruiting Shandong University · Dar es Salaam · NCT07319312

• Using a prediction tool to improve complete small-bowel exams with double-balloon enteroscopy

  This trial will test whether a preoperative prediction model helps doctors achieve complete small-bowel examination during double-balloon enteroscopy in adults being evaluated for suspected small-bowel disease.

  Recruiting at 5 sites Shandong University · Dezhou, Shandong and 4 other locations · NCT07288346

• Terbinafine dosing and blood levels in children with tinea capitis

  This study will test how oral terbinafine is processed in children aged 2–18 with tinea capitis and whether the weight-based dosing is safe and effective.

  Recruiting Shandong University · Beijing · NCT07046988

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.